|
Re: How common is this infectious pathway, or whatever the correct term is?
|
8
|
Resverlogix Corp.
|
Jan 04, 2021 08:55AM
|
|
Re: Could there be another shoe waiting to drop?
|
8
|
Resverlogix Corp.
|
May 20, 2019 05:00PM
|
|
Re: Peter Libby / You Tube Interview
|
8
|
Resverlogix Corp.
|
Aug 16, 2019 09:07AM
|
|
Another apabetalone/COVID-19 connection
|
8
|
Resverlogix Corp.
|
Apr 20, 2021 05:39PM
|
|
Epigenetic Therapeutic Targets Summit, 7/15/2021: Clinical Development of ZEN-3694 in Solid Tumors
|
8
|
Zenith Epigenetics
|
Jul 22, 2021 09:58AM
|
|
Re: The biggest unanswered question - Where's the money?
|
8
|
Resverlogix Corp.
|
Dec 07, 2019 10:42PM
|
|
Apabetalone MOA diagram
|
8
|
Resverlogix Corp.
|
Sep 28, 2019 08:55AM
|
|
Re: Slight Change of topic
|
8
|
Resverlogix Corp.
|
May 24, 2017 10:09PM
|
|
Target modulation
|
8
|
Zenith Epigenetics
|
Dec 20, 2016 12:44PM
|
|
Re: Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
|
8
|
Resverlogix Corp.
|
Jan 11, 2018 02:29PM
|
|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
8
|
Resverlogix Corp.
|
Nov 20, 2019 06:20AM
|
|
Re: Would a functional cure for T1D affect RVX and T2D?
|
8
|
Resverlogix Corp.
|
Jan 17, 2021 11:54AM
|
|
Re: AGM 2018 - Masila Notes
|
8
|
Resverlogix Corp.
|
Jun 13, 2019 11:34AM
|
|
Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study
|
8
|
Resverlogix Corp.
|
Sep 08, 2021 08:22AM
|
|
Re: “We will see how close we got”.....
|
8
|
Resverlogix Corp.
|
Nov 17, 2019 08:57AM
|
|
RVX-208 and Rosuvastatin Patent
|
8
|
Resverlogix Corp.
|
Dec 12, 2016 05:01PM
|
|
Re: Key Dates Over the Next Four Months
|
8
|
Resverlogix Corp.
|
Jul 21, 2019 07:58AM
|
|
Re: What an incredible...
|
8
|
Resverlogix Corp.
|
Dec 24, 2019 12:08AM
|
|
Zenith abstract at AACR
|
8
|
Resverlogix Corp.
|
Oct 26, 2015 10:57PM
|
|
Re: GV on stock house
|
8
|
Resverlogix Corp.
|
Apr 08, 2021 01:05PM
|
